Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bausch & Lomb restructuring

This article was originally published in The Tan Sheet

Executive Summary

Approximately 700 jobs worldwide to be eliminated by end of Q1 as part of ongoing plan aimed at reducing operating costs, firm announces Jan. 4. Roughly 250 jobs were cut during Q4 when firm closed contact lens manufacturing plants in Sarasota, Fla. and Madrid, Spain. Remaining restructuring will eliminate additional 450 positions, with cuts expected to be "broad-based " and "impact all regions and functional units," lens care company says. In December, new CEO Ronald Zarrella announced plans to trim personnel (1"The Tan Sheet" Dec. 10, 2001, p. 15)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093449

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel